{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:42:33Z","timestamp":1790685753600,"version":"4.1.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.molimm.2004.06.024","type":"journal-article","created":{"date-parts":[[2004,7,24]],"date-time":"2004-07-24T14:25:55Z","timestamp":1090679155000},"page":"153-160","source":"Crossref","is-referenced-by-count":51,"title":["Complement-opsonized HIV: the free rider on its way to infection"],"prefix":"10.1016","volume":"42","author":[{"given":"Heribert","family":"Stoiber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Pruenster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph G.","family":"Ammann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred P.","family":"Dierich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2004.06.024_BIB1","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1042\/bj2240389","article-title":"Localization of the complement\u2013component\u2013C3b-binding site and the cofactor activity for factor I in the 38 kDa tryptic fragment of factor H","volume":"224","author":"Alsenz","year":"1984","journal-title":"Biochem. J"},{"key":"10.1016\/j.molimm.2004.06.024_BIB2","doi-asserted-by":"crossref","first-page":"20231","DOI":"10.1074\/jbc.271.34.20231","article-title":"Molecular cloning and characterization of the human anaphylatoxin C3a receptor","volume":"271","author":"Ames","year":"1996","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.molimm.2004.06.024_BIB3","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.4049\/jimmunol.169.6.3301","article-title":"Opsonization of HIV-1 by semen complement enhances infection of human epithelial cells","volume":"169","author":"Bouhlal","year":"2002","journal-title":"J. Immunol"},{"key":"10.1016\/j.molimm.2004.06.024_BIB4","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.4049\/jimmunol.166.5.3377","article-title":"Soluble CD16 inhibits CR3 (CD11b\/CD18)-mediated infection of monocytes\/macrophages by opsonized primary R5 HIV-1","volume":"166","author":"Bouhlal","year":"2001","journal-title":"J. Immunol"},{"key":"10.1016\/j.molimm.2004.06.024_BIB5","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1365-3083.1992.tb03150.x","article-title":"Complement receptor type 2 mediates infection of the human CD4-negative Raji B-cell line with opsonized HIV","volume":"36","author":"Boyer","year":"1992","journal-title":"Scand. J. Immunol"},{"key":"10.1016\/j.molimm.2004.06.024_BIB6","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1084\/jem.173.5.1151","article-title":"Complement mediates human immunodeficiency virus type 1 infection of a human T cell line in a CD4- and antibody-independent fashion","volume":"173","author":"Boyer","year":"1991","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.molimm.2004.06.024_BIB7","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1074-7613(01)00098-X","article-title":"The CD19\/CD21 complex functions to prolong B cell antigen receptor signaling from lipid rafts","volume":"14","author":"Cherukuri","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.molimm.2004.06.024_BIB8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-3083.1993.tb01711.x","article-title":"Evidence for the role of CR1 (CD35), in addition to CR2 (CD21), in facilitating infection of human T cells with opsonized HIV","volume":"38","author":"Delibrias","year":"1993","journal-title":"Scand. J. Immunol"},{"key":"10.1016\/j.molimm.2004.06.024_BIB9","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1002\/eji.1830241131","article-title":"CR1(CD35) and CR2(CD21) complement C3 receptors are expressed on normal human thymocytes and mediate infection of thymocytes with opsonized human immunodeficiency virus","volume":"24","author":"Delibrias","year":"1994","journal-title":"Eur. J. Immunol"},{"key":"10.1016\/j.molimm.2004.06.024_BIB10","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0887-7963(91)70199-5","article-title":"The regulation of complement on cell surfaces","volume":"5","author":"Devine","year":"1991","journal-title":"Transfus. Med. Rev"},{"key":"10.1016\/j.molimm.2004.06.024_BIB11","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1083\/jcb.120.4.1031","article-title":"The I domain is a major recognition site on the leukocyte integrin Mac-1 (CD11b\/CD18) for four distinct adhesion ligands","volume":"120","author":"Diamond","year":"1993","journal-title":"J. Cell Biol"},{"key":"10.1016\/j.molimm.2004.06.024_BIB12","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1084\/jem.142.1.242","article-title":"C3-mediated cytoadherence. Formation of C3 receptor aggregates as prerequisite for cell attachment","volume":"142","author":"Dierich","year":"1975","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.molimm.2004.06.024_BIB13","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0167-5699(93)90246-H","article-title":"HIV and human complement: mechanisms of interaction and biological implication","volume":"14","author":"Dierich","year":"1993","journal-title":"Immunol. Today"},{"key":"10.1016\/j.molimm.2004.06.024_BIB14","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0171-2985(00)80035-2","article-title":"B cell-mediated infection of stimulated and unstimulated autologous T lymphocytes with HIV-1: role of complement","volume":"202","author":"Doepper","year":"2000","journal-title":"Immunobiology"},{"key":"10.1016\/j.molimm.2004.06.024_BIB15","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1002\/eji.200323932","article-title":"Mechanism(s) promoting HIV-1 infection of primary unstimulated T lymphocytes in autologous B cell\/T cell co-cultures","volume":"33","author":"Dopper","year":"2003","journal-title":"Eur. J. Immunol"},{"key":"10.1016\/j.molimm.2004.06.024_BIB16","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1084\/jem.174.6.1417","article-title":"Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41","volume":"174","author":"Ebenbichler","year":"1991","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.molimm.2004.06.024_BIB17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1146\/annurev.iy.13.040195.001015","article-title":"The CD19\/CR2\/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity","volume":"13","author":"Fearon","year":"1995","journal-title":"Annu. Rev. Immunol"},{"key":"10.1016\/j.molimm.2004.06.024_BIB18","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1097\/00002030-199612000-00004","article-title":"Acquisition of host cell-surface-derived molecules by HIV-1","volume":"10","author":"Frank","year":"1996","journal-title":"AIDS"},{"key":"10.1016\/j.molimm.2004.06.024_BIB19","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0092-8674(00)80694-7","article-title":"DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells","volume":"100","author":"Geijtenbeek","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.molimm.2004.06.024_BIB20","doi-asserted-by":"crossref","first-page":"11314","DOI":"10.1074\/jbc.M111532200","article-title":"Identification of different binding sites in the dendritic cell-specific receptor DC-SIGN for intercellular adhesion molecule 3 and HIV-1","volume":"277","author":"Geijtenbeek","year":"2002","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.molimm.2004.06.024_BIB21","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/349614a0","article-title":"The chemotactic receptor for human C5a anaphylatoxin","volume":"349","author":"Gerard","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.molimm.2004.06.024_BIB22","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1182\/blood.V81.7.1808.1808","article-title":"Complement and virus-specific antibody-dependent infection of normal B lymphocytes by human immunodeficiency virus type 1","volume":"81","author":"Gras","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2004.06.024_BIB23","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1128\/JVI.65.1.541-545.1991","article-title":"Antibody-dependent and antibody-independent complement-mediated enhancement of human immunodeficiency virus type 1 infection in a human. Epstein\u2013Barr virus-transformed B-lymphocytic cell line","volume":"65","author":"Gras","year":"1991","journal-title":"J. Virol"},{"key":"10.1016\/j.molimm.2004.06.024_BIB24","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/339070a0","article-title":"Activation of HIV gene expression during monocyte differentiation by induction of NF-kappa B","volume":"339","author":"Griffin","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.molimm.2004.06.024_BIB25","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1146\/annurev.immunol.17.1.625","article-title":"Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues","volume":"17","author":"Haase","year":"1999","journal-title":"Annu. Rev. Immunol"},{"key":"10.1016\/j.molimm.2004.06.024_BIB26","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nri1178","article-title":"Reassessing the function of immune-complex retention by follicular dendritic cells","volume":"3","author":"Haberman","year":"2003","journal-title":"Nat. Rev. Immunol"},{"key":"10.1016\/j.molimm.2004.06.024_BIB27","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/377740a0","article-title":"Follicular dendritic cells and human immunodeficiency virus infectivity","volume":"377","author":"Heath","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.molimm.2004.06.024_BIB28","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1016\/S0140-6736(02)09291-7","article-title":"Association of a pool of HIV-1 with erythrocytes in vivo: a cohort study","volume":"359","author":"Hess","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.molimm.2004.06.024_BIB29","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1046\/j.1365-2567.1999.00304.x","article-title":"B lymphocytes in lymph nodes and peripheral blood are important for binding immune complexes containing HIV-1","volume":"96","author":"Jakubik","year":"1999","journal-title":"Immunology"},{"key":"10.1016\/j.molimm.2004.06.024_BIB30","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1128\/JVI.74.1.552-555.2000","article-title":"Immune complexes containing human immunodeficiency virus type 1 primary isolates bind to lymphoid tissue B lymphocytes and are infectious for T lymphocytes","volume":"74","author":"Jakubik","year":"2000","journal-title":"J. Virol"},{"key":"10.1016\/j.molimm.2004.06.024_BIB31","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.4049\/jimmunol.150.3.1065","article-title":"Binding of human immunodeficiency virus type-1 to follicular dendritic cells in vitro is complement dependent","volume":"150","author":"Joling","year":"1993","journal-title":"J. Immunol"},{"key":"10.1016\/j.molimm.2004.06.024_BIB32","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00002030-199103000-00004","article-title":"Complement and antibody mediate enhancement of HIV infection by increasing virus binding and provirus formation","volume":"5","author":"June","year":"1991","journal-title":"AIDS"},{"key":"10.1016\/j.molimm.2004.06.024_BIB33","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.4049\/jimmunol.166.5.3410","article-title":"C5a and C5adesArg enhance the susceptibility of monocyte-derived macrophages to HIV infection","volume":"166","author":"Kacani","year":"2000","journal-title":"J. Immunol"},{"key":"10.1016\/j.molimm.2004.06.024_BIB34","doi-asserted-by":"crossref","first-page":"7997","DOI":"10.1128\/JVI.74.17.7997-8002.2000","article-title":"Detachment of human immunodeficiency virus type 1 from germinal centers by blocking complement receptor type 2","volume":"74","author":"Kacani","year":"2000","journal-title":"J. Virol"},{"key":"10.1016\/j.molimm.2004.06.024_BIB35","doi-asserted-by":"crossref","first-page":"812","DOI":"10.4049\/jimmunol.171.2.812","article-title":"Modular organization of the carboxyl-terminal, globular head region of human C1q A, B, and C chains","volume":"171","author":"Kishore","year":"2003","journal-title":"J. Immunol"},{"key":"10.1016\/j.molimm.2004.06.024_BIB36","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.bbapap.2003.08.003","article-title":"Localization of ligand-binding sites on human C1q globular head region using recombinant globular head fragments and single-chain antibodies","volume":"1652","author":"Kojouharova","year":"2003","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.molimm.2004.06.024_BIB37","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1034\/j.1600-065X.2001.1800110.x","article-title":"Structure\u2013function relationships of complement receptor type 1","volume":"180","author":"Krych-Goldberg","year":"2001","journal-title":"Immunol. Rev"},{"key":"10.1016\/j.molimm.2004.06.024_BIB38","doi-asserted-by":"crossref","first-page":"7549","DOI":"10.4049\/jimmunol.162.12.7549","article-title":"Complement receptor 1 (CD35) on human reticulocytes: normal expression in systemic lupus erythematosus and HIV-infected patients","volume":"162","author":"Lach-Trifilieff","year":"1999","journal-title":"J. Immunol"},{"key":"10.1016\/j.molimm.2004.06.024_BIB39","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/00042560-199702010-00002","article-title":"Complement activation by HIV-1-infected cells: the role of transmembrane glycoprotein gp41","volume":"14","author":"Marschang","year":"1997","journal-title":"J. Acquir. Immune Defic. Syndr. Hum. Retrovirol"},{"key":"10.1016\/j.molimm.2004.06.024_BIB40","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/eji.1830250147","article-title":"Decay-accelerating factor (CD55) protects human immunodeficiency virus type 1 from inactivation by human complement","volume":"25","author":"Marschang","year":"1995","journal-title":"Eur. J. Immunol"},{"key":"10.1016\/j.molimm.2004.06.024_BIB41","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1126\/science.1084238","article-title":"Recruitment of HIV and its receptors to dendritic cell\u2013T cell junctions","volume":"300","author":"McDonald","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.molimm.2004.06.024_BIB42","doi-asserted-by":"crossref","first-page":"4404","DOI":"10.1128\/JVI.63.10.4404-4408.1989","article-title":"Interleukin-1 and tumor necrosis factor alpha can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor","volume":"63","author":"Merrill","year":"1989","journal-title":"J. Virol"},{"key":"10.1016\/j.molimm.2004.06.024_BIB43","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1084\/jem.192.5.637","article-title":"B cells of HIV-1-infected patients bind virions through CD21-complement interactions and transmit infectious virus to activated T cells","volume":"192","author":"Moir","year":"2000","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.molimm.2004.06.024_BIB44","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/infdis\/173.1.60","article-title":"Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors","volume":"173","author":"Montefiori","year":"1996","journal-title":"J. Infect. Dis"},{"key":"10.1016\/j.molimm.2004.06.024_BIB45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2249.1997.d01-890.x","article-title":"Extrahepatic complement biosynthesis: where, when and why?","volume":"107","author":"Morgan","year":"1997","journal-title":"Clin. Exp. Immunol"},{"key":"10.1016\/j.molimm.2004.06.024_BIB46","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.4049\/jimmunol.153.5.2021","article-title":"Expression of type 3 complement receptor on activated CD8+ T cells facilitates homing to inflammatory sites","volume":"153","author":"Nielsen","year":"1994","journal-title":"J. Immunol"},{"key":"10.1016\/j.molimm.2004.06.024_BIB47","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nm0398-341","article-title":"Evolutionary pattern of human immunodeficiency virus (HIV) replication and distribution in lymph nodes following primary infection: implications for antiviral therapy","volume":"4","author":"Pantaleo","year":"1998","journal-title":"Nat. Med"},{"key":"10.1016\/j.molimm.2004.06.024_BIB48","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1089\/aid.1995.11.971","article-title":"HIV glycoprotein 41 and complement factor H interact with each other and share functional as well as antigenic homology","volume":"11","author":"Pinter","year":"1995","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.molimm.2004.06.024_BIB49","unstructured":"Prodinger, W.M., Wuerzner, R., Stoiber, H., Dierich, M.P., 2003. Complement. In: Paul, Fundamental Immunology, fifth ed. Lippincott-Raven, Philadelphia, pp. 1077\u20131105."},{"key":"10.1016\/j.molimm.2004.06.024_BIB50","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.4049\/jimmunol.135.4.2687","article-title":"Human follicular dendritic cells express CR1, CR2, and CR3 complement receptor antigens","volume":"135","author":"Reynes","year":"1985","journal-title":"J. Immunol"},{"key":"10.1016\/j.molimm.2004.06.024_BIB51","doi-asserted-by":"crossref","first-page":"4847","DOI":"10.1128\/JVI.71.6.4847-4851.1997","article-title":"Contribution of virion ICAM-1 to human immunodeficiency virus infectivity and sensitivity to neutralization","volume":"71","author":"Rizzuto","year":"1997","journal-title":"J. Virol"},{"key":"10.1016\/j.molimm.2004.06.024_BIB52","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S0140-6736(88)91695-9","article-title":"Will antibody-dependent enhancement of HIV-1 infection be a problem with AIDS vaccines?","volume":"1","author":"Robinson","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.molimm.2004.06.024_BIB53","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/0042-6822(90)90449-2","article-title":"Complement-mediated antibody-dependent enhancement of HIV-1 infection requires CD4 and complement receptors","volume":"175","author":"Robinson","year":"1990","journal-title":"Virology"},{"key":"10.1016\/j.molimm.2004.06.024_BIB54","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1089\/088922201750252025","article-title":"Enhanced avidity maturation of antibody to human immunodeficiency virus envelope: DNA vaccination with gp120-C3d fusion proteins","volume":"17","author":"Ross","year":"2001","journal-title":"AIDS Res. Hum. Retrovirol"},{"key":"10.1016\/j.molimm.2004.06.024_BIB55","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1172\/JCI118190","article-title":"Antibody-dependent complement-mediated cytotoxicity in sera from patients with HIV-1 infection is controlled by CD55 and CD59","volume":"96","author":"Schmitz","year":"1995","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.molimm.2004.06.024_BIB56","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1046\/j.1365-2567.2003.01707.x","article-title":"Inhibition of DC-SIGN-mediated trans infection of T cells by mannose-binding lectin","volume":"110","author":"Spear","year":"2003","journal-title":"Immunology"},{"key":"10.1016\/j.molimm.2004.06.024_BIB57","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1128\/JVI.75.6.2604-2516.2001","article-title":"Human immunodeficiency virus type 1 induced expression of complement factors in human astrocytes","volume":"75","author":"Speth","year":"2001","journal-title":"J. Virol"},{"key":"10.1016\/j.molimm.2004.06.024_BIB58","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S0171-2985(01)80016-4","article-title":"Enhancement of complement-mediated lysis by a peptide derived from SCR 13 of complement factor H","volume":"203","author":"Stoiber","year":"2001","journal-title":"Immunobiology"},{"key":"10.1016\/j.molimm.2004.06.024_BIB59","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1146\/annurev.immunol.15.1.649","article-title":"Role of complement in HIV infection","volume":"15","author":"Stoiber","year":"1997","journal-title":"Annu. Rev. Immunol"},{"key":"10.1016\/j.molimm.2004.06.024_BIB60","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0161-5890(97)00108-9","article-title":"Inhibition of HIV-1 infection in vitro by monoclonal antibodies to the complement receptor type 3 (CR3): an accessory role for CR3 during virus entry?","volume":"34","author":"Stoiber","year":"1997","journal-title":"Mol. Immunol"},{"key":"10.1016\/j.molimm.2004.06.024_BIB61","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1034\/j.1600-065X.2001.1800115.x","article-title":"The supportive role of complement in HIV pathogenesis","volume":"180","author":"Stoiber","year":"2001","journal-title":"Immunol. Rev"},{"key":"10.1016\/j.molimm.2004.06.024_BIB62","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1084\/jem.183.1.307","article-title":"Efficient destruction of human immunodeficiency virus in human serum by inhibiting the protective action of complement factor H and decay accelerating factor (DAF, CD55)","volume":"183","author":"Stoiber","year":"1996","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.molimm.2004.06.024_BIB63","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0264-410X(03)00203-2","article-title":"Role of complement in the control of HIV dynamics and pathogenesis","volume":"21","author":"Stoiber","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2004.06.024_BIB64","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/eji.1830240203","article-title":"The envelope glycoprotein of HIV-1 gp120 and human complement protein C1q bind to the same peptides derived from three different regions of gp41, the transmembrane glycoprotein of HIV-1, and share antigenic homology","volume":"24","author":"Stoiber","year":"1994","journal-title":"Eur. J. Immunol"},{"key":"10.1016\/j.molimm.2004.06.024_BIB65","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.4049\/jimmunol.157.4.1791","article-title":"Susceptibility of HIV-1 plasma virus to complement-mediated lysis. Evidence for a role in clearance of virus in vivo","volume":"157","author":"Sullivan","year":"1996","journal-title":"J. Immunol"},{"key":"10.1016\/j.molimm.2004.06.024_BIB66","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1182\/blood.V87.6.2329.bloodjournal8762329","article-title":"Identification of complement activation sites in human immunodeficiency virus type-1 glycoprotein gp120","volume":"87","author":"Susal","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2004.06.024_BIB67","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1146\/annurev.iy.07.040189.000515","article-title":"Microanatomy of lymphoid tissue during humoral immune responses: structure function relationships","volume":"7","author":"Szakal","year":"1989","journal-title":"Annu. Rev. Immunol"},{"key":"10.1016\/j.molimm.2004.06.024_BIB68","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1006\/viro.1998.9205","article-title":"Mechanisms of resistance of HIV-1 primary isolates to complement-mediated lysis","volume":"246","author":"Takefman","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.molimm.2004.06.024_BIB69","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1086\/345953","article-title":"Influence of co-infection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy","volume":"36","author":"Tedaldi","year":"2003","journal-title":"Clin. Infect. Dis"},{"key":"10.1016\/j.molimm.2004.06.024_BIB70","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.4049\/jimmunol.155.10.4861","article-title":"Triggering of complement receptors CR1 (CD35) and CR3 (CD11b\/CD18) induces nuclear translocation of NF-kappa B (p50\/p65) in human monocytes and enhances viral replication in HIV-infected monocytic cells","volume":"155","author":"Thieblemont","year":"1995","journal-title":"J. Immunol"},{"key":"10.1016\/j.molimm.2004.06.024_BIB71","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1078\/0171-2985-00155","article-title":"Interaction of C1q and mannan-binding lectin with viruses","volume":"205","author":"Thielens","year":"2002","journal-title":"Immunobiology"},{"key":"10.1016\/j.molimm.2004.06.024_BIB72","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1365-2249.1994.tb06040.x","article-title":"Antibody-dependent enhancement of HIV-1 infection in human term syncytiotrophoblast cells cultured in vitro","volume":"96","author":"Toth","year":"1994","journal-title":"Clin. Exp. Immunol"},{"key":"10.1016\/j.molimm.2004.06.024_BIB73","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1084\/jem.171.5.1791","article-title":"Complement receptor 2 mediates enhancement of human immunodeficiency virus 1 infection in Epstein\u2013Barr virus-carrying B cells","volume":"171","author":"Tremblay","year":"1990","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.molimm.2004.06.024_BIB74","first-page":"33","article-title":"CD59: a molecule involved in antigen presentation as well as downregulation of membrane attack complex","volume":"9","author":"Venneker","year":"1992","journal-title":"Exp. Clin. Immunogenet"},{"key":"10.1016\/j.molimm.2004.06.024_BIB75","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1146\/annurev.iy.13.040195.001425","article-title":"Transcriptional regulation of complement genes","volume":"13","author":"Volanakis","year":"1995","journal-title":"Annu. Rev. Immunol"},{"key":"10.1016\/j.molimm.2004.06.024_BIB76","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1182\/blood.V79.1.152.152","article-title":"Binding of fluorescein-labeled anaphylatoxin C5a to human peripheral blood, spleen, and bone marrow leukocytes","volume":"79","author":"Werfel","year":"1992","journal-title":"Blood"}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589004002263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589004002263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T02:44:45Z","timestamp":1682736285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589004002263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":76,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0161589004002263"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2004.06.024","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}